| lymphocyte differentiation | GO:0030098 | 242 | 0.684 | |
| stem cell development | GO:0048864 | 219 | 0.490 | |
| stem cell maintenance | GO:0019827 | 130 | 0.462 | |
| lateral inhibition | GO:0046331 | 1 | 0.428 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.404 | |
| regionalization | GO:0003002 | 337 | 0.381 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.368 | |
| stem cell differentiation | GO:0048863 | 268 | 0.354 | |
| neural tube closure | GO:0001843 | 90 | 0.325 | |
| t cell differentiation | GO:0030217 | 174 | 0.304 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.290 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.280 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.212 | Human |
| neural tube development | GO:0021915 | 160 | 0.212 | |
| gonad development | GO:0008406 | 141 | 0.200 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.178 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.175 | |
| respiratory system development | GO:0060541 | 190 | 0.162 | |
| chromatin modification | GO:0016568 | 187 | 0.161 | |
| primary neural tube formation | GO:0014020 | 95 | 0.161 | |
| t cell activation | GO:0042110 | 289 | 0.159 | |
| establishment of planar polarity involved in neural tube closure | GO:0090177 | 15 | 0.157 | |
| tube closure | GO:0060606 | 91 | 0.157 | |
| rhythmic process | GO:0048511 | 174 | 0.152 | |
| tube formation | GO:0035148 | 140 | 0.149 | |
| gland development | GO:0048732 | 330 | 0.147 | |
| male gamete generation | GO:0048232 | 285 | 0.147 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.145 | |
| cerebellar granule cell precursor tangential migration | GO:0021935 | 1 | 0.138 | |
| histone modification | GO:0016570 | 159 | 0.138 | |
| locomotory behavior | GO:0007626 | 195 | 0.137 | |
| lung development | GO:0030324 | 164 | 0.133 | |
| cell fate commitment | GO:0045165 | 210 | 0.130 | |
| establishment of planar polarity | GO:0001736 | 28 | 0.129 | |
| chromatin organization | GO:0006325 | 206 | 0.123 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.121 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.118 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.116 | |
| epithelial tube formation | GO:0072175 | 130 | 0.115 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.104 | |
| cardiac cell fate specification | GO:0060912 | 2 | 0.103 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.103 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.102 | |
| calcium ion transport | GO:0006816 | 159 | 0.102 | |
| male sex differentiation | GO:0046661 | 109 | 0.101 | |
| protein deacetylation | GO:0006476 | 32 | 0.098 | |
| rhombomere formation | GO:0021594 | 1 | 0.098 | |
| non canonical wnt signaling pathway | GO:0035567 | 33 | 0.096 | |
| skeletal system development | GO:0001501 | 356 | 0.096 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.096 | |
| somitogenesis | GO:0001756 | 69 | 0.094 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.092 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.086 | |
| methylation | GO:0032259 | 134 | 0.085 | |
| neural tube formation | GO:0001841 | 108 | 0.085 | |
| ovarian follicle development | GO:0001541 | 40 | 0.085 | |
| notch signaling pathway | GO:0007219 | 71 | 0.084 | |
| hindbrain development | GO:0030902 | 128 | 0.083 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.079 | |
| synapse organization | GO:0050808 | 125 | 0.079 | |
| respiratory tube development | GO:0030323 | 167 | 0.078 | |
| angiogenesis | GO:0001525 | 201 | 0.075 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.074 | |
| renal system development | GO:0072001 | 225 | 0.074 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.073 | |
| stem cell proliferation | GO:0072089 | 117 | 0.073 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.071 | |
| spermatogenesis | GO:0007283 | 284 | 0.071 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.070 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.070 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.070 | |
| regulation of binding | GO:0051098 | 111 | 0.069 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.069 | |
| cartilage development | GO:0051216 | 140 | 0.069 | |
| neuroblast differentiation | GO:0014016 | 2 | 0.067 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.065 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.065 | Human |
| axonogenesis | GO:0007409 | 274 | 0.064 | |
| neuroblast fate determination | GO:0007400 | 1 | 0.064 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.064 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.064 | |
| wnt signaling pathway planar cell polarity pathway | GO:0060071 | 27 | 0.063 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.063 | |
| forebrain development | GO:0030900 | 302 | 0.063 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.063 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.062 | |
| establishment of planar polarity of embryonic epithelium | GO:0042249 | 16 | 0.062 | |
| circadian rhythm | GO:0007623 | 114 | 0.061 | |
| negative regulation of fat cell differentiation | GO:0045599 | 36 | 0.061 | |
| muscle tissue development | GO:0060537 | 308 | 0.061 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.061 | |
| cell cell signaling involved in cell fate commitment | GO:0045168 | 35 | 0.059 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.059 | |
| compartment pattern specification | GO:0007386 | 4 | 0.057 | |
| nephron development | GO:0072006 | 109 | 0.056 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.056 | |
| muscle fiber development | GO:0048747 | 76 | 0.055 | |
| genitalia development | GO:0048806 | 37 | 0.055 | |
| histone deacetylation | GO:0016575 | 26 | 0.054 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.054 | |
| cilium morphogenesis | GO:0060271 | 102 | 0.054 | |
| somite development | GO:0061053 | 81 | 0.053 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.053 | |
| female sex differentiation | GO:0046660 | 84 | 0.052 | |
| protein deacylation | GO:0035601 | 36 | 0.051 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.051 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.051 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.051 | |
| nephron epithelium development | GO:0072009 | 92 | 0.051 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.050 | |
| cation transport | GO:0006812 | 399 | 0.049 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.049 | |
| epidermis development | GO:0008544 | 187 | 0.049 | |
| dephosphorylation | GO:0016311 | 129 | 0.049 | |
| regulation of establishment of planar polarity | GO:0090175 | 28 | 0.049 | |
| macromolecule deacylation | GO:0098732 | 37 | 0.048 | |
| heart valve morphogenesis | GO:0003179 | 21 | 0.048 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.048 | |
| mesonephros development | GO:0001823 | 97 | 0.048 | |
| mitral valve development | GO:0003174 | 4 | 0.048 | |
| oocyte axis specification | GO:0007309 | 2 | 0.046 | |
| planar cell polarity pathway involved in neural tube closure | GO:0090179 | 14 | 0.046 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.045 | |
| cell adhesion | GO:0007155 | 329 | 0.045 | |
| basal protein localization | GO:0045175 | 1 | 0.045 | |
| positive regulation of notch signaling pathway | GO:0045747 | 18 | 0.045 | |
| digestive system development | GO:0055123 | 200 | 0.045 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.045 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.044 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.044 | |
| regulation of cell activation | GO:0050865 | 289 | 0.044 | |
| cellular homeostasis | GO:0019725 | 240 | 0.044 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.044 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.044 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.044 | |
| regulation of neuron death | GO:1901214 | 134 | 0.044 | |
| compound eye development | GO:0048749 | 1 | 0.043 | |
| segmentation | GO:0035282 | 93 | 0.042 | |
| fat cell differentiation | GO:0045444 | 160 | 0.042 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.042 | |
| cellular response to lipid | GO:0071396 | 145 | 0.042 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.042 | |
| spinal cord development | GO:0021510 | 81 | 0.042 | |
| neurohypophysis development | GO:0021985 | 2 | 0.042 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.041 | |
| blastocyst development | GO:0001824 | 80 | 0.041 | |
| negative regulation of dendritic spine development | GO:0061000 | 3 | 0.041 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.041 | |
| dendrite development | GO:0016358 | 115 | 0.041 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.041 | |
| placenta development | GO:0001890 | 140 | 0.041 | |
| regulation of mammary gland epithelial cell proliferation | GO:0033599 | 12 | 0.040 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.040 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.040 | |
| male gonad development | GO:0008584 | 88 | 0.040 | |
| stem cell division | GO:0017145 | 30 | 0.040 | |
| neuron projection guidance | GO:0097485 | 141 | 0.040 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.039 | |
| vagus nerve morphogenesis | GO:0021644 | 2 | 0.039 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.039 | |
| urogenital system development | GO:0001655 | 261 | 0.039 | |
| adaptive immune response | GO:0002250 | 155 | 0.039 | |
| negative regulation of cell fate specification | GO:0009996 | 4 | 0.039 | |
| appendage development | GO:0048736 | 166 | 0.039 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.039 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.039 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.038 | |
| cell cell adhesion via plasma membrane adhesion molecules | GO:0098742 | 40 | 0.038 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.038 | |
| defecation | GO:0030421 | 1 | 0.038 | |
| microtubule based process | GO:0007017 | 236 | 0.037 | |
| response to growth factor | GO:0070848 | 198 | 0.037 | |
| body morphogenesis | GO:0010171 | 45 | 0.037 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.037 | |
| response to light stimulus | GO:0009416 | 135 | 0.037 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.037 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.037 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.036 | |
| fourth ventricle development | GO:0021592 | 2 | 0.036 | |
| mammary gland lobule development | GO:0061377 | 22 | 0.036 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.036 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.036 | |
| regulation of store operated calcium entry | GO:2001256 | 4 | 0.036 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.035 | |
| oocyte construction | GO:0007308 | 2 | 0.035 | |
| head morphogenesis | GO:0060323 | 34 | 0.035 | |
| neuroblast fate commitment | GO:0014017 | 1 | 0.034 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.034 | |
| connective tissue development | GO:0061448 | 179 | 0.034 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.034 | |
| embryonic digit morphogenesis | GO:0042733 | 56 | 0.034 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.034 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.034 | |
| tissue homeostasis | GO:0001894 | 115 | 0.034 | |
| developmental maturation | GO:0021700 | 193 | 0.034 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.034 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 38 | 0.033 | |
| aortic valve morphogenesis | GO:0003180 | 4 | 0.033 | |
| maintenance of location | GO:0051235 | 89 | 0.033 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.033 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.033 | |
| establishment of tissue polarity | GO:0007164 | 28 | 0.033 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.033 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.032 | |
| cilium assembly | GO:0042384 | 81 | 0.032 | |
| transdifferentiation | GO:0060290 | 1 | 0.032 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.032 | |
| b cell activation | GO:0042113 | 161 | 0.032 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.032 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.032 | |
| anion transport | GO:0006820 | 177 | 0.032 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.032 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.032 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.032 | |
| regulation of dna binding | GO:0051101 | 39 | 0.031 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.031 | |
| dna metabolic process | GO:0006259 | 303 | 0.031 | Human |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.030 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.030 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.030 | |
| renal tubule development | GO:0061326 | 87 | 0.030 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.030 | |
| cd4 positive alpha beta t cell activation | GO:0035710 | 45 | 0.030 | |
| positive regulation of secondary heart field cardioblast proliferation | GO:0072513 | 4 | 0.030 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.029 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.029 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.029 | |
| regulation of cell migration | GO:0030334 | 219 | 0.029 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.029 | |
| response to radiation | GO:0009314 | 165 | 0.029 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.029 | |
| regulation of establishment of planar polarity involved in neural tube closure | GO:0090178 | 15 | 0.029 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.028 | Human |
| protein catabolic process | GO:0030163 | 221 | 0.028 | |
| neuron death | GO:0070997 | 154 | 0.028 | |
| store operated calcium entry | GO:0002115 | 7 | 0.028 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.028 | |
| epithelial cell development | GO:0002064 | 159 | 0.028 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.028 | Human |
| gene silencing | GO:0016458 | 38 | 0.028 | |
| olfactory learning | GO:0008355 | 2 | 0.027 | |
| carbon catabolite activation of transcription from rna polymerase ii promoter | GO:0000436 | 4 | 0.027 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.027 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.027 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.027 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.027 | |
| regulation of epithelial to mesenchymal transition | GO:0010717 | 22 | 0.027 | |
| ectodermal cell differentiation | GO:0010668 | 3 | 0.027 | |
| histone methylation | GO:0016571 | 71 | 0.027 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.027 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.027 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.027 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.027 | |
| dna templated transcription termination | GO:0006353 | 4 | 0.027 | |
| response to monosaccharide | GO:0034284 | 67 | 0.027 | |
| pharynx development | GO:0060465 | 1 | 0.027 | |
| bone morphogenesis | GO:0060349 | 78 | 0.027 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.027 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.027 | |
| regulation of ossification | GO:0030278 | 112 | 0.027 | |
| mrna transcription from rna polymerase ii promoter | GO:0042789 | 4 | 0.026 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.026 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.026 | |
| cellular glucose homeostasis | GO:0001678 | 52 | 0.026 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.026 | |
| limb development | GO:0060173 | 166 | 0.026 | |
| macromolecule methylation | GO:0043414 | 120 | 0.026 | |
| positive regulation of fibroblast growth factor receptor signaling pathway | GO:0045743 | 3 | 0.026 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.026 | |
| megakaryocyte differentiation | GO:0030219 | 26 | 0.025 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.025 | |
| regulation of protein binding | GO:0043393 | 60 | 0.025 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.025 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.025 | |
| regulation of mrna metabolic process | GO:1903311 | 43 | 0.025 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.025 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.024 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.024 | |
| cellular response to glucose stimulus | GO:0071333 | 45 | 0.024 | |
| establishment of protein localization to membrane | GO:0090150 | 54 | 0.024 | |
| regulation of notch signaling pathway | GO:0008593 | 35 | 0.024 | |
| b cell differentiation | GO:0030183 | 78 | 0.024 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.024 | |
| regulation of neural retina development | GO:0061074 | 3 | 0.024 | |
| digestive tract development | GO:0048565 | 190 | 0.024 | |
| heart valve development | GO:0003170 | 23 | 0.024 | |
| regulation of ureteric bud formation | GO:0072106 | 3 | 0.024 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.024 | |
| nuclear division | GO:0000280 | 158 | 0.024 | |
| dna repair | GO:0006281 | 107 | 0.024 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.024 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.024 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.024 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.023 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.023 | |
| blastocyst formation | GO:0001825 | 33 | 0.023 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.023 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.023 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.023 | |
| limb morphogenesis | GO:0035108 | 149 | 0.023 | |
| positive regulation of binding | GO:0051099 | 49 | 0.023 | |
| kidney development | GO:0001822 | 213 | 0.023 | |
| negative regulation of bmp signaling pathway | GO:0030514 | 35 | 0.023 | |
| regulation of cell motility | GO:2000145 | 236 | 0.023 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.023 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.023 | |
| epithelial to mesenchymal transition | GO:0001837 | 47 | 0.022 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.022 | |
| ossification | GO:0001503 | 216 | 0.022 | |
| aorta morphogenesis | GO:0035909 | 22 | 0.022 | |
| somatic stem cell division | GO:0048103 | 19 | 0.022 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.022 | |
| regulation of cardiac cell fate specification | GO:2000043 | 1 | 0.022 | |
| nuclear transport | GO:0051169 | 139 | 0.022 | |
| sensory perception | GO:0007600 | 245 | 0.022 | |
| metanephros development | GO:0001656 | 79 | 0.022 | |
| lung morphogenesis | GO:0060425 | 50 | 0.022 | |
| response to acid chemical | GO:0001101 | 111 | 0.022 | |
| cellular response to hexose stimulus | GO:0071331 | 47 | 0.021 | |
| organic acid transport | GO:0015849 | 101 | 0.021 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.021 | |
| positive regulation of lymphocyte apoptotic process | GO:0070230 | 13 | 0.021 | |
| regulation of protein deacetylation | GO:0090311 | 17 | 0.021 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.021 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.021 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.021 | |
| negative regulation of calcium ion dependent exocytosis | GO:0045955 | 3 | 0.021 | |
| positive regulation of stem cell differentiation | GO:2000738 | 23 | 0.021 | |
| multicellular organism growth | GO:0035264 | 161 | 0.021 | |
| regulation of circadian sleep wake cycle sleep | GO:0045187 | 3 | 0.021 | |
| regulation of protein localization | GO:0032880 | 231 | 0.021 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.021 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.020 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.020 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.020 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.020 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.020 | |
| mammary gland alveolus development | GO:0060749 | 22 | 0.020 | |
| midgut development | GO:0007494 | 4 | 0.020 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.020 | |
| myotube differentiation | GO:0014902 | 105 | 0.020 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.020 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.020 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.020 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.020 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.020 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.020 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.020 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.020 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.020 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.020 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.020 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.020 | |
| camera type eye development | GO:0043010 | 266 | 0.020 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.020 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.020 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.020 | |
| synapse assembly | GO:0007416 | 56 | 0.019 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.019 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.019 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.019 | |
| cell migration involved in endocardial cushion formation | GO:0003273 | 3 | 0.019 | |
| mrna metabolic process | GO:0016071 | 84 | 0.019 | |
| rhombomere morphogenesis | GO:0021593 | 2 | 0.019 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.019 | |
| vesicle organization | GO:0016050 | 60 | 0.019 | |
| lung cell differentiation | GO:0060479 | 30 | 0.019 | |
| negative regulation of osteoblast proliferation | GO:0033689 | 4 | 0.019 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.019 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.019 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.019 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.019 | |
| positive regulation of leukocyte apoptotic process | GO:2000108 | 21 | 0.019 | |
| regulation of actin polymerization or depolymerization | GO:0008064 | 45 | 0.019 | |
| neuroblast proliferation | GO:0007405 | 49 | 0.019 | |
| chemorepulsion of branchiomotor axon | GO:0021793 | 1 | 0.019 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.019 | |
| cardiac right atrium morphogenesis | GO:0003213 | 3 | 0.018 | |
| palate development | GO:0060021 | 76 | 0.018 | |
| oogenesis | GO:0048477 | 56 | 0.018 | |
| regulation of exocytosis | GO:0017157 | 61 | 0.018 | |
| circadian behavior | GO:0048512 | 13 | 0.018 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.018 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.018 | |
| brain segmentation | GO:0035284 | 3 | 0.018 | |
| cochlea morphogenesis | GO:0090103 | 22 | 0.018 | |
| cell recognition | GO:0008037 | 83 | 0.018 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.018 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.018 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.018 | |
| regulation of protein ubiquitination | GO:0031396 | 52 | 0.018 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.018 | |
| face morphogenesis | GO:0060325 | 29 | 0.018 | |
| positive regulation of t cell differentiation | GO:0045582 | 52 | 0.018 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.018 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.018 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.018 | |
| negative regulation of platelet derived growth factor receptor signaling pathway | GO:0010642 | 7 | 0.018 | |
| germ cell development | GO:0007281 | 185 | 0.018 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.018 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.018 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.017 | |
| gtp metabolic process | GO:0046039 | 144 | 0.017 | |
| rna processing | GO:0006396 | 105 | 0.017 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.017 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.017 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.017 | |
| negative regulation of dendritic spine morphogenesis | GO:0061002 | 3 | 0.017 | |
| rhythmic behavior | GO:0007622 | 15 | 0.017 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.017 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.017 | |
| regulation of carbohydrate biosynthetic process | GO:0043255 | 40 | 0.017 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.017 | |
| cell maturation | GO:0048469 | 127 | 0.017 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.017 | |
| metanephric mesenchymal cell migration | GO:0035789 | 2 | 0.017 | |
| glucose homeostasis | GO:0042593 | 128 | 0.017 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.017 | |
| cell migration involved in metanephros development | GO:0035788 | 2 | 0.017 | |
| embryonic hemopoiesis | GO:0035162 | 23 | 0.017 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.017 | |
| cell cell signaling involved in mammary gland development | GO:0060764 | 2 | 0.016 | |
| histone lysine methylation | GO:0034968 | 50 | 0.016 | |
| heart morphogenesis | GO:0003007 | 178 | 0.016 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.016 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.016 | |
| regulation of cardioblast differentiation | GO:0051890 | 3 | 0.016 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.016 | |
| response to amino acid | GO:0043200 | 37 | 0.016 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.016 | |
| regulation of fibroblast proliferation | GO:0048145 | 34 | 0.016 | |
| gtp catabolic process | GO:0006184 | 143 | 0.016 | |
| mrna processing | GO:0006397 | 63 | 0.016 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.016 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.016 | |
| protein maturation | GO:0051604 | 176 | 0.016 | |
| negative regulation of cell size | GO:0045792 | 3 | 0.016 | |
| endocardial cushion to mesenchymal transition involved in heart valve formation | GO:0003199 | 4 | 0.015 | |
| negative regulation of glial cell proliferation | GO:0060253 | 4 | 0.015 | |
| spleen development | GO:0048536 | 39 | 0.015 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.015 | |
| mrna splicing via spliceosome | GO:0000398 | 43 | 0.015 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.015 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.015 | |
| fibroblast growth factor receptor signaling pathway | GO:0008543 | 46 | 0.015 | |
| protein alkylation | GO:0008213 | 81 | 0.015 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.015 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.015 | |
| ovulation cycle | GO:0042698 | 59 | 0.015 | |
| establishment or maintenance of cytoskeleton polarity | GO:0030952 | 2 | 0.015 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.015 | |
| anion transmembrane transport | GO:0098656 | 71 | 0.015 | |
| chemotaxis | GO:0006935 | 247 | 0.015 | |
| positive regulation of lymphocyte differentiation | GO:0045621 | 61 | 0.015 | |
| ventricular system development | GO:0021591 | 27 | 0.015 | |
| positive regulation of mitotic metaphase anaphase transition | GO:0045842 | 2 | 0.015 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.015 | |
| cell division | GO:0051301 | 120 | 0.015 | |
| negative regulation of photoreceptor cell differentiation | GO:0046533 | 4 | 0.014 | |
| myoblast differentiation | GO:0045445 | 52 | 0.014 | |
| regulation of secretion | GO:0051046 | 274 | 0.014 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.014 | |
| positive regulation of protein modification by small protein conjugation or removal | GO:1903322 | 30 | 0.014 | |
| heart field specification | GO:0003128 | 6 | 0.014 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.014 | |
| homophilic cell adhesion via plasma membrane adhesion molecules | GO:0007156 | 18 | 0.014 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.014 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.014 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.014 | |
| oxidation reduction process | GO:0055114 | 342 | 0.014 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.014 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.014 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.014 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.014 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.014 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.014 | |
| positive regulation of transcription from rna polymerase ii promoter in response to stress | GO:0036003 | 3 | 0.014 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.014 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.014 | |
| organelle fission | GO:0048285 | 170 | 0.014 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.014 | |
| glossopharyngeal nerve morphogenesis | GO:0021615 | 4 | 0.014 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.014 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.014 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.014 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.014 | |
| regulation of stem cell maintenance | GO:2000036 | 17 | 0.014 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.014 | |
